SEATTLE, Nov. 14, 2023 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), today announced third quarter financial results for the period ended September 30, 2023 and provided recent business highlights.. “Our commitment to advancing targeted alpha-particle therapies against neuroendocrine tumors remains steadfast as we have completed dosing of the…Read More
Perspective Therapeutics Inc Perspective Therapeutics Reports Third Quarter Fiscal 2023 Results and Recent Business Highlights
